Jon Brett-Harris

Jon Brett-Harris is Executive Vice President of the Pharmaceutical and Chemical Markets strategic business unit for Thomson Reuters. His responsibilities include the Liquent, IDRAC, Newport, Prous Science and CMR businesses.

Prior to joining Thomson in March 2006, Jon held management and leadership roles within the pharmaceutical and biotechnology industry. He had also operated his own company with activities focused on pharmaceutical licensing, venture funding and executive coaching.

Jon holds a Bachelor of Science degree in Psychology and Economics and an MBA, both from the University of London.

US Guest Speaker: Jeffrey S. Ross, M.D.

Dr. Ross is a graduate of Oberlin College, Oberlin, Ohio and The State University of New York at Buffalo School of Medicine in Buffalo, New York. He served as an intern resident and fellow in Anatomic and Clinical Pathology at the Massachusetts General Hospital in Boston, Massachusetts. He was certified by the American Board of Pathology in Anatomic and Clinical Pathology in 1974.

Dr. Ross has received numerous academic awards, three patents in molecular diagnostics and is the author of more than 550 peer-reviewed scientific articles, research abstracts, 3 textbooks and numerous book chapters in the fields of pathology, molecular diagnostics, oncology and translational cancer research. At Albany Medical College, Dr. Ross directs an extramurally funded research laboratory in molecular pathology.

. . . . .

European Guest Speaker: Dr. Trevor T. Hansel, Medical Director
National Heart & Lung (NHLI) Clinical Studies Unit

Dr. Golden is Chief Technology Officer of SAIC's Life Sciences Office where he is focused on search and intelligence analysis, including unstructured text mining, competitive intelligence and social networks. Previously he has held positions in market intelligence, business development and informatics at Life Science Insights, 454 Corporation, CuraGen, GeneSys Technologies, and Pioneer Hi-Bred.

Dr. Golden is a Major in the U.S. Air Force Reserve and spent several years on the staff of the Air Force Test Pilot School. Dr. Golden has a B.S. in mathematics and computer science from Rhodes College, Memphis,TN; an M.S. in computer science from the University of Tennessee Space Institute in Tullahoma, TN; and a Ph.D. in mechanical engineering from Vanderbilt University (design and optimization of DNA sequencing devices).

Rachel Blair-Davies
Product Management, Pharma/Chem
Thomson Reuters

After graduating from University College London with a Biochemistry degree (BSc Hons), Rachel joined Current Drugs (acquired by Thomson) in 1996 in the Editorial department working specifically on the drug and company information within IDdb. Since then, Rachel has enjoyed various roles in sales, account managment, technical support, customer training and customer values & feedback, mostly related to IDdb and Thomson Pharma.

She is now a Product Manager responsible for the strategy and future roadmap of existing and new business development & licensing solutions for the pharmaceutical & biotech industry.

Mark Gordon
Director, Product Strategy & Marketing Pharma/Chem
Thomson Reuters

Mark has twenty years of experience helping companies improve business performance using information technology. He spent much of the last ten years helping pharmaceutical companies develop business processes and systems to support the identification, evaluation and pursuit of research collaboration, drug licensing and merger and acquisition opportunities, as well as competitive intelligence.

Mark is currently evaluating biopharma market needs for analytical solutions and information and using those assessments to drive Thomson Reuters's product strategy.

To present at Princeton event:
Rachel Blair-Davies

Krysia Chomka
Manager, Product Management
Pharma/Chem
Thomson Reuters

Krysia starting working for Derwent Information (now part of Thomson Reuters) 8 years ago after leaving Sheffield University with a Masters Degree in Chemistry. Krysia initially worked as a senior patent analyst compiling abstracts and indexing pharmaceutical patents for the DWPI database.

She then moved to internal product training, helping the sales team learn about the products and gain an understanding of the drug development pipeline. After being in this role for 2 years Krysia moved to a customer facing role to help address customer specific needs and accompanying sales on customer visits.

This job has now evolved and Krysia now works within the Product Management team, which helps shape the development of the pharmaceutical product portfolio.

Mike Chace
Senior Director, Product Strategy, API Intelligence
Thomson Reuters

Mike is responsible for managing the long-term development of Newport’s products and services for generic companies and innovators. In this role he works closely with customers to understand their current and future needs and ensures that our offerings are able to adapt and respond as appropriate, maximizing their business value and capabilities.

Most recently, Mike led the Custom Solutions Team within the Pharma/Chem business of TS, having joined Newport Strategies in 2003 as New Business Development Director, and later as Product Specialist.

Previously, Mike was a Managing Consultant with PA Consulting Group’s Life Science & Technology practice in Cambridge, MA. He has also held management positions in the Life Science practices of Barnett International/PAREXEL and with Deloitte Consulting in Philadelphia, PA and Bath, UK.

Dave Harding
Sales Support Specialist, API Intelligence
Thomson Reuters

Dave joined Thomson Scientific in 2005 as a
member of Newport’s research team which
specializes in gathering competitive intelligence on the worldwide active ingredients market and the generic pharmaceutical sector. In 2007, Dave took on an additional role of supporting Thomson’s global sales force during the sales of Newport’s systems, including Vision CI which is used by many innovators for CI and sourcing purposes. In this dual role, Dave has traveled to many countries of the world, including India, China, and Japan. Dave earned a BS in Economics with Business minor from the University of Utah.

Krysia Chomka
Manager, Product Management
Pharma/Chem
Thomson Reuters

Krysia starting working for Derwent Information (now part of Thomson Reuters) 8 years ago after leaving Sheffield University with a Masters Degree in Chemistry. Krysia initially worked as a senior patent analyst compiling abstracts and indexing pharmaceutical patents for the DWPI database.

She then moved to internal product training, helping the sales team learn about the products and gain an understanding of the drug development pipeline. After being in this role for 2 years Krysia moved to a customer facing role to help address customer specific needs and accompanying sales on customer visits.

This job has now evolved and Krysia now works within the Product Management team, which helps shape the development of the pharmaceutical product portfolio.

US Guest Speaker: Jeffrey S. Ross, M.D., Senior Scientific Advisor Prous Science

Dr. Ross is a graduate of Oberlin College, Oberlin, Ohio and The State University of New York at Buffalo School of Medicine in Buffalo, New York. He served as an intern resident and fellow in Anatomic and Clinical Pathology at the Massachusetts General Hospital in Boston, Massachusetts. He was certified by the American Board of Pathology in Anatomic and Clinical Pathology in 1974.

Dr. Ross has received numerous academic awards, three patents in molecular diagnostics and is the author of more than 550 peer-reviewed scientific articles, research abstracts, 3 textbooks and numerous book chapters in the fields of pathology, molecular diagnostics, oncology and translational cancer research. At Albany Medical College, Dr. Ross directs an extramurally funded research laboratory in molecular pathology.

. . . . .

European Guest Speaker: Dr. Trevor T. Hansel, Medical Director
National Heart & Lung (NHLI) Clinical Studies Unit

Colin Williams
Product Manager, Biology & Bioinformatics
Pharma/Chem
Thomson Reuters

Colin Williams is the Product Manager for Biology and Bioinformatics at Thomson Reuters. He studied Biochemistry at the University of Sheffield before completing a PhD in protein X-ray crystallography. Following post doctoral work he moved to ASM Scientific, a start-up biotechnology company in Cambridge UK.

Here, as part of a team of three, he developed a novel isothermal DNA amplification technology for use in point of care pathogen detection and contributed towards patent applications for the technology. Subsequent to this he joined Thomson Reuters as GENESEQ Editorial and Content manager in November 2005. Here he was responsible for optimizing production in terms of timeliness and quality, but also examining potential content changes and additions to the product. In June 2007 he moved into his current role where he is responsible for developing solutions for Biologists and those working with this information.

Ann Wescott
Head of Product & Business Development, Thomson Reuters Spain (Prous Science)

Ann Wescott is Head of Product & Business Development at Prous Science, a Thomson Reuters business. Ann has been with Prous Science for more than 20 years and participated in the development of all the company's drug R&D databases, starting with diskette and classic online formats in the 1980s and progressing to the Prous Science Integrity drug discovery and development portal on the Internet.

Ann Wescott
Head of Product & Business Development, Thomson Reuters Spain (Prous Science)

Ann Wescott is Head of Product & Business Development at Prous Science, a Thomson Reuters business. Ann has been with Prous Science for more than 20 years and participated in the development of all the company's drug R&D databases, starting with diskette and classic online formats in the 1980s and progressing to the Prous Science Integrity drug discovery and development portal on the Internet.

Colin Williams
Product Manager, Biology & Bioinformatics
Pharma/Chem
Thomson Reuters

Colin Williams is the Product Manager for Biology and Bioinformatics at Thomson Reuters. He studied Biochemistry at the University of Sheffield before completing a PhD in protein X-ray crystallography. Following post doctoral work he moved to ASM Scientific, a start-up biotechnology company in Cambridge UK.

Here, as part of a team of three, he developed a novel isothermal DNA amplification technology for use in point of care pathogen detection and contributed towards patent applications for the technology. Subsequent to this he joined Thomson Reuters as GENESEQ Editorial and Content manager in November 2005. Here he was responsible for optimizing production in terms of timeliness and quality, but also examining potential content changes and additions to the product. In June 2007 he moved into his current role where he is responsible for developing solutions for Biologists and those working with this information.

Princeton Speaker: Jane S. Ricciuti, RPh, MS
Director, Regulatory & Pharmaceutical Research
Pharma/Chem
Thomson Reuters

Jane S. Ricciuti is a graduate of Albany College of Pharmacy, Albany, New York with a Bachelor of Science degree in Pharmacy and Johns Hopkins University, Baltimore, Maryland with a Master of Administrative Science degree in Management. She has worked previously as a licensed pharmacist in patient care and clinical trials in the acute care, oncology, and surgery settings.

Currently, Jane Ricciuti is the Director, Regulatory & Pharmaceutical Research for the Scientific business of Thomson Reuters and responsible for researching new products and enhancements in the areas of pharmaceutical and biotechnology regulatory affairs. She is also responsible for writing expert documents for the IDRAC database on all US regulations pertaining to drugs, biologics, and medical devices.

San Mateo Speaker: Walter E. Chalkley, RAC
Senior Editor IDRAC
Pharma/Chem
Thomson Reuters

Walter Chalkley is a graduate of Virginia Commonwealth University and is RAC certified through the Regulatory Affairs Professional Society. Currently, Walter is a Senior Editor in the US Module of IDRAC in the Scientific business of Thomson Reuters. His responsibilities include meeting coverage and editing the various IDRAC US product documents.

London Speaker: Odile Le Roy des Barres
Director, Product Management
Regulatory Information
Thomson Reuters

Odile is Product Management Director for IDRAC since 2003, she is responsible for the evolutions of the IDRAC services.
Her key role is to ensure that IDRAC provides the best Regulatory intelligence solution for customers. Odile is in close contacts with customers and account managers to ensure their needs are addressed. She also responsible for the strategic marketing of IDRAC.
Previously, Odile held a variety of roles in sales and sales management for Europe and Japan.

Odile is a Pharmacist Doctor and holds several degrees in clinical trial. She started to work at IDRAC from its conception in 1993.

European Speaker: Riccardo Sciabica
Senior Editor IDRAC
Pharma/Chem
Thomson Reuters

Riccardo Sciabica is a Senior Editor within IDRAC, a Thomson Reuters service, which is the leading Drug Regulatory Information database covering all the legislation and practical regulatory information needed to launch and maintain medicinal products on the market in 55 countries. In his role at IDRAC, Riccardo is responsible for maintaining and updating the EU module and for coordinating the activity of all the teams in charge of the European countries modules.

Riccardo joined IDRAC as an Editor for the European and International legislation in 2002. Prior to joining IDRAC, Riccardo worked as a medical representative at Alfa-Wassermann, he also spent several months as a trainee within the European Medicines Agency (EMEA).

He gained his PharmD in 1997 at the Faculty of Pharmacy of the University of Palermo (Italy) and his Master in Regulatory Affairs in the European Union in 1999 at the Faculty of Pharmacy of the University of Lille (France).

Princeton Speaker: Gaye Miller
Product Technical Trainer
Pharma/Chem
Thomson Reuters

Gaye Miller joined Thomson Scientific in November 2004 as part of the Information Holdings - Thomson merger. Prior to the merger she was the Customer Care/Training Manager for IDRAC in North America. Gaye has 13 years training experience and resides in Bucks County, PA.

. . . . .

To present at San Mateo event:
Kathy Gaddar
Product Technical Trainer
Pharma/Chem
Thomson Reuters

Mark Gordon
Director, Product Strategy & Marketing Pharma/Chem
Thomson Reuters

Mark has twenty years of experience helping companies improve business performance using information technology. He spent much of the last ten years helping pharmaceutical companies develop business processes and systems to support the identification, evaluation and pursuit of research collaboration, drug licensing and merger and acquisition opportunities, as well as competitive intelligence.

Mark is currently evaluating biopharma market needs for analytical solutions and information and using those assessments to drive Thomson Reuters's product strategy.

Princeton & London Speaker: Wendy Hamilton
Vice President, Marketing & Product Strategy
Pharma/Chem
Thomson Reuters

Wendy recently joined the Thomson Reuters executive team, coming from the Liquent business within Thomson.

Wendy has spent over fifteen years in developing strategy for applications in the pharmaceutical industry including time with GSK, Merck and Astra Zeneca (via Accenture). She has a broad background ranging across technology, product management, product marketing and business strategy and leverages all of these in her current role of Vice President of Product Strategy for Thomson Reuters Pharma unit.

London Speaker: Annabel Griffiths
Director, Director, Customs Solutions
Thomson Reuters

Annabel Griffiths has been with Thomson Reuters for 10 years. Annabel’s current role as Custom Solutions Director for Europe involves working with our pharmaceutical and chemical clients to deliver customized content and technology solutions focused on specific client needs. Annabel is based in London and holds a . BA in Social Science and Business Psychology.

Princeton & San Mateo Speaker: Pat Dennin
Director, North American Customs Solutions
Pharma/Chem
Thomson Reuters

Prior to join Thomson Reuters in May of 2002 Mr. Dennin has had various positions in the Information Technology business since 1986. His background includes custom installations of business systems for the retail, hospitality, financial, pharmaceutical and manufacturing markets. He has worked for several leading technology companies, NCR, MicroAge, Broadwing and Core BTS. Mr. Dennin has also provided consulting services for Dell Computer and Acer.

Currently he leads the Custom Solutions team in North America for the Scientific Business of Thomson Reuters focusing on the Pharma and Biotech industries.

Pat Dennin
Director, North American Customs Solutions
Pharma/Chem
Thomson Reuters

Prior to join Thomson Reuters in May of 2002 Mr. Dennin has had various positions in the Information Technology business since 1986. His background includes custom installations of business systems for the retail, hospitality, financial, pharmaceutical and manufacturing markets. He has worked for several leading technology companies, NCR, MicroAge, Broadwing and Core BTS. Mr. Dennin has also provided consulting services for Dell Computer and Acer.

Currently he leads the Custom Solutions team in North America for the Scientific Business of Thomson Reuters focusing on the Pharma and Biotech industries.